| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017252933 |
| P356 | DOI | 10.1038/SJ.BJC.6605509 |
| P932 | PMC publication ID | 2822943 |
| P698 | PubMed publication ID | 20051945 |
| P5875 | ResearchGate publication ID | 40850768 |
| P2093 | author name string | L J Vatten | |
| G Tranø | |||
| H H Wasmuth | |||
| E Hofsli | |||
| W Sjursen | |||
| P2860 | cites work | BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer | Q28239788 |
| Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics | Q28253670 | ||
| A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer | Q28289377 | ||
| Microsatellite instability and MLH1 promoter hypermethylation in colorectal cancer | Q28299711 | ||
| The biochemical basis of microsatellite instability and abnormal immunohistochemistry and clinical behavior in Lynch syndrome: from bench to bedside | Q33762979 | ||
| Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene | Q33904639 | ||
| Pathology features in Bethesda guidelines predict colorectal cancer microsatellite instability: a population-based study | Q34102606 | ||
| Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. | Q34414061 | ||
| Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). | Q34557362 | ||
| Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer | Q34563305 | ||
| BRAF screening as a low-cost effective strategy for simplifying HNPCC genetic testing | Q35446668 | ||
| BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum | Q35596687 | ||
| Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis | Q35747184 | ||
| Genetic predisposition to colorectal cancer | Q35930688 | ||
| Hereditary colorectal cancer syndromes | Q36158014 | ||
| Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians | Q36548203 | ||
| Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome. Part II. The utility of microsatellite instability testing | Q36734614 | ||
| Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer). | Q36746989 | ||
| Hereditary nonpolyposis colorectal cancer families not complying with the Amsterdam criteria show extremely low frequency of mismatch-repair-gene mutations | Q42037545 | ||
| Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management | Q47301537 | ||
| BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair | Q47617017 | ||
| Mutations in hMSH6 alone are not sufficient to cause the microsatellite instability in colorectal cancer cell lines | Q52828898 | ||
| Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas | Q53373414 | ||
| Inheritance of a Cancer-AssociatedMLH1Germ-Line Epimutation | Q56588356 | ||
| Incidence of Hereditary Nonpolyposis Colorectal Cancer and the Feasibility of Molecular Screening for the Disease | Q57567959 | ||
| Identification in Daily Practice of Patients With Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Revised Bethesda Guidelines-Based ApproachVersusMolecular Screening | Q58408232 | ||
| Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC) | Q73963449 | ||
| Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome) | Q79803580 | ||
| Decoding hereditary colorectal cancer | Q79810701 | ||
| Identifying Lynch syndrome: we are all responsible | Q81747619 | ||
| Awareness of heredity in colorectal cancer patients is insufficient among clinicians: a Norwegian population-based study | Q84029354 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colorectal carcinoma | Q25493920 |
| colorectal cancer | Q188874 | ||
| Lynch syndrome | Q783644 | ||
| P304 | page(s) | 482-488 | |
| P577 | publication date | 2010-01-05 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study | |
| P478 | volume | 102 |
| Q38364721 | A massive parallel sequencing workflow for diagnostic genetic testing of mismatch repair genes |
| Q35469854 | Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer? |
| Q36041678 | Colorectal cancer survivors' interest in genetic testing for hereditary cancer: implications for universal tumor screening |
| Q34289520 | Current clinical criteria for Lynch syndrome are not sensitive enough to identify MSH6 mutation carriers |
| Q54377350 | Differential diagnostics of hereditary colorectal cancer syndromes. The role of pathology |
| Q43052904 | Discrimination of patients with microsatellite instability colon cancer using 1H HR MAS MR spectroscopy and chemometric analysis |
| Q46042535 | Evaluation of predictive models in daily practice for the identification of patients with Lynch syndrome |
| Q38205339 | Familial colorectal cancer type X: genetic profiles and phenotypic features. |
| Q44449817 | Identification of metastasis-associated microRNAs in serum from rectal cancer patients. |
| Q36993526 | Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study |
| Q37994931 | Lynch or Not Lynch? Is that Always a Question? |
| Q82989175 | Lynch syndrome: genetics and surgery |
| Q37892037 | Management of young onset colorectal cancer: divergent practice in the East of England |
| Q45172873 | Multidisciplinary management of colorectal cancer enhances access to multimodal therapy and compliance with National Comprehensive Cancer Network (NCCN) guidelines |
| Q43453576 | Patient and tumor characteristics may raise clinicians' awareness of familial colorectal cancer: A Norwegian population-based study |
| Q83821808 | Simplified identification of Lynch syndrome: A prospective, multicenter study |
| Q64259739 | Small RNA expression from viruses, bacteria and human miRNAs in colon cancer tissue and its association with microsatellite instability and tumor location |
| Q35063442 | Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing. |
| Q89326750 | Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma |
Search more.